1. Home
  2. BZH vs AURA Comparison

BZH vs AURA Comparison

Compare BZH & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beazer Homes USA Inc.

BZH

Beazer Homes USA Inc.

HOLD

Current Price

$33.37

Market Cap

890.0M

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.00

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BZH
AURA
Founded
1985
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
890.0M
797.5M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
BZH
AURA
Price
$33.37
$6.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
★ $32.00
$20.00
AVG Volume (30 Days)
628.1K
★ 633.3K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,087,739,000.00
N/A
Revenue This Year
$4.36
N/A
Revenue Next Year
$10.79
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$17.83
$4.73
52 Week High
$34.54
$9.54

Technical Indicators

Market Signals
Indicator
BZH
AURA
Relative Strength Index (RSI) 63.10 29.59
Support Level $33.07 $5.30
Resistance Level $33.98 $6.34
Average True Range (ATR) 0.06 0.30
MACD -0.04 -0.10
Stochastic Oscillator 81.58 7.45

Price Performance

Historical Comparison
BZH
AURA

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in states and metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the sources of revenue for the company. Its segments involve: West segment that includes Arizona, California, Nevada, and Texas; East segment that includes Delaware, Indiana, Maryland, Tennessee, and Virginia; and Southeast segment which includes Florida, Georgia, North Carolina, and South Carolina.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: